Chc Meditech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 09-01-2025
- Paid Up Capital ₹ 1.00 M
as on 09-01-2025
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.01 M
as on 09-01-2025
- Revenue 78.04%
(FY 2016)
- Profit 4656.87%
(FY 2016)
- Ebitda 212.52%
(FY 2016)
- Net Worth 12.03%
(FY 2016)
- Total Assets -4.91%
(FY 2016)
About Chc Meditech
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹2.01 M.
The Key Managerial Personnel (KMP) at Chc Meditech Private Limited India are Senthil Kandeepan as CEO and Jayasri Kandeepan as Cfo. Chinnappa Kowsalya, Jayasri Kandeepan, and Senthil Kandeepan serve as directors at the Company.
- CIN/LLPIN
U33110DL2010PTC198824
- Company No.
198824
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Feb 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Chc Meditech?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayasri Kandeepan  | CFO | 28-Aug-2020 | Current |
| Senthil Kandeepan | CEO | 08-Feb-2010 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chinnappa Kowsalya | Director | 18-Dec-2018 | Current |
Financial Performance of Chc Meditech.
Chc Meditech Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 78.04% increase. The company also saw a substantial improvement in profitability, with a 4656.87% increase in profit. The company's net worth Soared by an impressive increase of 12.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chc Meditech?
In 2016, Chc Meditech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Health Watch Tele Diagnostics Private LimitedActive 13 years 7 monthsChinnappa Kowsalya, Senthil Kandeepan and 3 more are mutual person
Chc Homeicu Private LimitedActive 2 years 4 monthsJayasri Kandeepan and Senthil Kandeepan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 05 Apr 2011 | ₹2.01 M | Open |
How Many Employees Work at Chc Meditech?
Unlock and access historical data on people associated with Chc Meditech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chc Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chc Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
